<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="167">
  <!-- This xml conforms to:  http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>Information obtained from ClinicalTrials.gov on October 20, 2011</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01178463</url>
  </required_header>
  <id_info>
    <org_study_id>HYMC-0065-09</org_study_id>
    <nct_id>NCT01178463</nct_id>
  </id_info>
  <brief_title>Spermatogonial Stem Cells in Azoospermic Patients: a Comparison Between Obstructive and Non-obstructive Azoospermia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers hypothesized that nonobstructive azoospermia might be associated with a
      reduction OF SSCs in seminiferous tubules as compared with obstructive azoospermia.
      Testicular sperm  specimens that had been previously extracted from azoospermic patients
      will be paraffin embedded and stained with anti GPR-125. After antigen retrieval, the
      sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit
      secondary antibodies. Those found to be SSCs will be counted using light microscopy, and
      compared between patients with obstructive (n=11) and non-obstructive azoospermia (n=9).
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model:  Cohort, Time Perspective:  Retrospective</study_design>
  <primary_outcome>
    <measure>SSCs were identified in both obstructive and nonobstructive azoospermia patients.</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Male Infertility</condition>
  <arm_group>
    <arm_group_label>I.  Obstructive Azoospermia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>II. Non-Obstructive Azoospermia Patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biospecimen staining</intervention_name>
    <description>The sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit secondary antibodies.</description>
    <arm_group_label>I.  Obstructive Azoospermia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biospecimen staining</intervention_name>
    <description>The sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit secondary antibodies.</description>
    <arm_group_label>II. Non-Obstructive Azoospermia Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infertile male patients treated at the Hillel Yaffe Medical Center IVF Unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Azoospermic patients

        Exclusion Criteria:

          -  Patients with sperm cells
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center - IVF Unit</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <lastchanged_date>August 9, 2010</lastchanged_date>
  <firstreceived_date>August 9, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Adrian Ellenbogen</name_title>
    <organization>Hillel Yaffe Medical Center</organization>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
</clinical_study>
